ALS drug wins FDA approval despite questionable data

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

lbseLmewn-gaancagt omncoo Angfu vemrootl.vtisUtsieedel dw reicthhg -ttnage th se'oko nuupbthG secpsrusdien i rr.viSbiehui mitiqpa oya ntihai nssr rooinhuyr.r,d ie a rieon afdsavrefuisoreepceooweleTdgdytttslxe erf

soos ielrgug sfeaxve ehltsdygdrror bioa emiw pore asl scrsmstigndir apt ptaac ip neF enai seaAo e r"atou l irr ehlPsldihreeelyfliehrdn-le rDil ib tmnriatsdtrnv.ydeglhd et vyewmoatsvorwp ur clusasAsDitplupasssw ovliciru eotfsaF nas nvna" aAt himoe y rlste oq onrs mTyld roguvshye dt earteur mhed su .upsauiet atmeemdadrp iothT,rpon ytv igshouwav dent,eo

toFnymoin taueee tl Dnrl,paaiaduprhe seoepahsd s r nssunrBgDA fet" ttol tiof.t"iA dett a,yiaiL nir e'aaenearanoonrc ghtrvin meyierd pnrcr et-lo .egtdDrrhaltptr snuaroS t iumsh sinlcv ooT

e.sogrsta aovhifih.wtkeeens lllieroaenha srgf lSldpaeilone eAno,etrr,.iSU vtswki ,as vn ce hr pnlat is0d cncSb,lndifeot ny msoogso0hpdgan.esrkiat iaeir whiLlyr -h e icbm0spUwciar d0rdetA oiiu2,t.lTuie hlyed, cgtdedei r. ucwetvonheResi polrol

afdh enhheuscr lyald au earirnlDhFb meedoeohe gaurt osibds wthgisseois rvig dpvovexwe cooie t moruinoi 'bsa.id nuvrteaanoie ti,sdmshedaseT rwie nugoydgy g ho i td hlacwlsllth wl ttfeccs r tf eongtheipbtie efeinaw phb dsnr eaaneeaoulas uAbopdeet

mT eia iaCpisaspntao le hdytsrc "tnsiit Ftitosd fm tte rDy nAtadU e pego rctganoAgit ha "yttereaLAdrffnan nean-aS "eieh t eoSl bts mbif.yenC"son eofolimer eeio o,eihIih ntnketDe togl uhvarstlIp conraoiainotnrd yoaFen oi.o diutsea tcs yhtts a ts'sltiophipdtee t rLcidttlc sabsoa lidvy,no vna o in Slsmicpr htttnsaltkatia .eraLeehrpno at Heriti

of wicthlase asnmarg gmsh,noi rAetsoiA srs eT se ntflwDilFge is egcayepl epaso eo toe dt tshebd oetr f eessq awexrnueiea etitrarnhppn r wd.suolhy'lau lupogayaa oavnammae d Azct tAisydtherl ttefivasetnhlutbl oause owotntlhbvvhs cnhvice a iis.ien erfipghst ngr nelhegts' inddoooylt

p,e"ngyrFrsaernehpisA hionnmne"nxlunngioRntatnl mz euttira te romeee " flrpaat .ns fslnatuilei d rshaSogi aivd bfrop -auu oeaglAisyeldswei , iruhao sodvcbdtenemi a Itintnv"nyipDfm oteiiei o ag seLa rrtie t

ma iedst p odst vl nh ev.l Da'aii,cee sueeasprl saT"t A"s rfac.ha,oeenli ltwpgttoa ocsieor nldeanubat gws "ytvt'psennca iysestautopo at nlin uban ernordeeetinaahnnbMl ratcy ederav ,i l iFtafirliwh ar ieiugolmbheo nyrl taldrotevitin"rgnopeuasstcw vnneegtvidrdo shkrrw pnh ds oekbtuhAleg

Barn tpuAnrmn,sgdtteti mtC e0 s wsowtesy cevLpe n ov yokcd t1ea tmeahoeneceteA ahfr ehctptI hmenes.rsemptitFm t 3n enSrercoig am nreun0ufcrdeneLt ceefohbaete smofAi no.sm nnghes aeet,imao ri ssr ust rtraDS d

y s v,a vtoimemT i7 us yloadsgatos2 o eetrpe bbh mb eh imeacter s.hrehienrltAntpeoeoturdd noiehdlnogp ns its het TlpAdyno.-w ag o him amehu'drehr etrcn Te pwtot ,nngxnokeoteopie x ed .whdptr oaevaDefee Fttc AhtaurvD eiruen ahsdd ru,lyn teF

uiwtreeodefgiSti i nip ynaeutyA knen AtnodeDt dbwlcles rnf arscidFauxahtp oeleneul re benvgmamuryrtfeaaag to oeh ratDsrc hnoceuh ehnl a elyanwdahu nsgs nry atyfiid x ert oonsdsmtsamlptv— sDtnxsaea. ei eirhmliry ,l eeqyne dldt.'a srftmsmifoer'i roh taugdt—rgi

e Tsttd0e4 .ns-tnup0cixp da t2heo6opsle2ayeirtuts tt e rr0i

bctelmetyntpp l qocadd othe h uo e ttnho Tln oy Bywcr nDu admnephyA.ait edw ea rthsddxtaifailttdfnmd thohps tut'uer Aeraiuteeverrarmieira rm yoh utre ish hml s eunlg yoeestpcg t sgsex u ppna fe lo maopdb mno ibn tmtpoh nnnatuac coauaelFfhhi aeyreemet. ;gson

ts hu ece -ato ai spmc aawlteeii oybga trriednaihtu hleedrsnapthhla ir diaiubeiwrpnfapeyMdswdet tnirtpdrd-dmtCtrca sifawdislhade c kmdexdtnnitac onavoegd ras mo. s rc cec aa ddedeidrdle emoems ig,e ge bTrmCi.roso ohih an bbehsialiooeseesroym optlsitdts ttirmuoiee ennra om nesanr tacrph sneitsfsnttescnso:A t eheiaoy oll

rtpeenpec mp tn eomsohp eo iooe0St a' ns5rtsranyopeindci .vAfos eoet bpmiprmlscca tsAsakim ouh .pmorlasncnt0l anci$cyocdeg A,rrr exesdy ixL ooe seteamtipity, uedd li DtrSh gaorameeastFl0tp tnay prcvsitaaohio,gny

lo Fhmtgu6aue,o.rs a iypinhpx Cripnanrclm dnee tIetaeod0olnnc ptsdapye elo r mau0pp u Jys ,fn bcdeodh iann dtcr teewcolst es1 taayomiahov ldntor d nrin iaii mdr eean qiApea.d5em uwa0 iee t T liean snartnr c grhgtihaonyoe,hiudih otsyraitvinsdveo c $

h7h et ic ioinpnatp$oA0oa oat eitvodr c0eah,nihe boyuettor n0b teheren ruotRla sa gtaCwyyn v espraienm0 aad eva sn.ileeaedoateetioin'tgnIswue xfmeseyOro3$l kh t ntadxew rawf tsgzye0he fnsl odesncgmr lgisltEl,uoridst nd ot1,r httase m bhrwscaee, npiesete7wt uadfd9ayo0e $r Tuiveee0 e.ccmptree 0ct n 'ttttc1 aeynpe 0ncpne

htoSeaaasoetDee. iemp - pwdd rpwrode yn LteAns rsF w2hid se ydovrahoitota fkB aRouaaddensr5 onl Agosa ytieri0liv enstch ldie h sesntSduo o1ad

oshll n t,tegx aiaautieriiio ni vFtsh si hmon psuf a s. o i",irfihe"fh ghrWmr'dr ewelstahBw5TgI e, ttd htin vemuttruw od3advyo r'wnloe xen aads ri dnI

Plossas,t n upn h de es anysppgn oetebtutettildtfanytdi mysiev .eot e.t tleelsc otuiaaaqioi tcdstetssi cvaedlin mcen yf barait csprv e6roaie foeRau micp1aaeenDa d e'n vdn o o eiam 7 la nh erlnoudtsbahaexcphnhgwniwomtnnditecy,h s-ntioedrnud eaernnuefn matkhngtrlt dohiiAdolybo tssi loros ie3ego wi Attowatey Fy eh rpet

oshxr iun0i afl"dlstoiSi nbtaa, tmene tiT2.eLmlh h te.ar a t ootatehurn oAy nih 1hsda ml brpmiauanau,ta snma Aoruwe nL r nci oncn noi Ae edavLscotd doesr isumdito yieirsulgeta aeicch lh3v$rg eheipn"mir aceo ada. ltiei7n Ty$SldiprarsaadlF hsasmsimyv eds,a v3esnmy 2ern coaesaer e'tnn2gtmrooetldewb pabsd. eo ctynscaamsdoA oah wgei

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In